Page 1

Auto-injectors Market Analysis, Size, Growth, Share & Forecast to 2026 | Grand View Research Inc.

“Auto-injectors Market Size Worth $3.2 Billion by 2026 | CAGR: 19.5%�

The global auto-injectors market size is expected to reach USD 3.18 billion by 2026, according to a new report by Grand View Research, Inc, exhibiting a CAGR of 19.5%. Rising incidence of anaphylactic shock and other diseases such as diabetes, rheumatoid, & multiple sclerosis along with increasing approvals of auto-injectors are impelling growth. Increasing prevalence of life-threatening allergies and rising demand for these devices are expected to aid growth. As per the Food Allergy Research & Education, around 200, 000 people every year need emergency medical care for allergic food reactions. In addition, increasing approvals are anticipated to drive growth. For instance, in August 2018, U.S. FDA approved the first generic epinephrine auto-injector of Teva Pharmaceuticals to treat emergency allergic reactions, including anaphylaxis. Generic versions of EpiPen Jr & EpiPen of 0.15 mg & 0.3 mg, respectively, are indicated for pediatric and adult patients weighing more than 33 pounds.

Moreover, manufacturers are also developing new products and innovative technologies, which is expected to propel market growth. For instance, in June 2018, AbbVie GK launched Humira, which is a fully human antitumor necrosis factor alpha monoclonal antibody formulation with lock function & injection start & end alerts as well as an inspection window and injects completely in 10 seconds. Demand for these devices is increasing as they are designed in accordance with patient acceptance and compliance. Technological advancements are anticipated to make them more convenient and userfriendly. This is encouraging patients to adopt this technology for chronic illnesses. For Latest research study :@ https://www.grandviewresearch.com/industry-analysis/auto-injectors-market

Follow Us:


Further key findings from the report suggest: • Disposable auto-injectors emerged as the largest segment owing to convenience and ease of use •

Homecare settings accounted for largest share in end-use segment owing to increasing demand of products for daily administration of insulin

North America dominated the auto-injectors market with largest share in 2018. Increasing demand for new technologies along with advanced healthcare infrastructure is expected to boost market growth during the forecast period

Asia Pacific is expected to witness fastest growth during the forecast period owing to increasing number of diabetic patients

Some of the key players are Eli Lilly; Scandinavian Health Ltd.; AbbVie, Inc.; Amgen; Owen Mumford; Ypsomed; Teva Pharmaceutical; Biogen Idec; Mylan N.V.; Pfizer, Inc.; and Sanofi

Grand View Research has segmented the global auto-injectors market based on product type, disease indication, end use, and region: Auto-injectors Product Type Outlook (Revenue, USD Million, 2015 - 2026) • Disposable Auto-Injectors •

Reusable Auto-Injectors o

Prefilled Auto-Injectors

o

Empty Auto-Injectors

Auto-injectors Disease Indication Outlook (Revenue, USD Million, 2015 - 2026) • Rheumatoid Arthritis •

Multiple Sclerosis

Diabetes

Anaphylaxis

Other Therapies

Auto-injectors End-use Outlook (Revenue, USD Million, 2015 - 2026) • Homecare Settings •

Hospitals & Clinics

Ambulatory Surgical Centers

Table of Contents Chapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Product type

Follow Us:


1.1.2. Disease indication 1.1.3. Regional scope 1.1.4. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis (Model 1) 1.6.1.1. Approach 1: Commodity flow approach 1.6.2. Volume price analysis (Model 2) 1.6.2.1. Approach 2: Volume price analysis 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives 1.9.1. Objective 1 1.9.2. Objective 2 1.9.3. Objective 3 1.9.4. Objective 4 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.3. Competitive Insights Chapter 3. Auto-injectors Market Variables, Trends, & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping

Follow Us:


3.3. Product Pipeline Analysis, by Stage 3.4. Market Dynamics 3.4.1. Market driver analysis 3.4.1.1. Growing prevalence of targeted therapies 3.4.1.2. Increase in the incidence of anaphylactic shock 3.4.1.3. Patients preference to choose self-administration of injections 3.4.2. Market restraint analysis Continue…………………. About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com

Follow Us:

Profile for Grand View Research

Auto-injectors Market Analysis Covering Market Size, Growth Factors, Demand, Trends And Forecast  

The global auto-injectors market size is expected to reach USD 3.18 billion by 2026, according to a new report by Grand View Research, Inc,...

Auto-injectors Market Analysis Covering Market Size, Growth Factors, Demand, Trends And Forecast  

The global auto-injectors market size is expected to reach USD 3.18 billion by 2026, according to a new report by Grand View Research, Inc,...

Advertisement